← Back to Patent Explorer
US5554748A Expired / Lapsed US ⏱️ 0.0 years remaining

Adducts of macrocyclic chelants

Assignee: Amersham Health Salutar Inc
•
Filing: 1993-12-30
•
Granted: 1996-09-10
•
Expires: 2013-12-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There are provided polychelants and their metal chelates which are useful in diagnostic imaging and in radiotherapy and which comprise a plurality of macrocyclic chelant moieties, e.g. DOTA residues, conjugated to a polyamine backbone molecule, e.g. polylysine. To produce a site-specific polychelate, one or more of the macrocyclic chelant carrying backbone molecules may be conjugated to a site-directed macromolecule, e.g. a protein. For example, adducts of a macrocyclic chelant can be formed by the process of (a) dispersing a carboxylic macrocyclic chelant in a polar, anhydrous solvent, (b) adding a base with a pKa sufficient to remove all carboxyl protons to create an amine salt of the chelant soluble in the solvent, (c) chilling the reaction mixture to between about 5 DEG C. and 55 DEG C. above the freezing point of the solvent, and (d) adding substantial equimolar amount of chilled alkylhaloformate under anhydrous conditions so as to form a slurry containing the mixture carboxycarbonic anhydride of the chelant.

Inventors

  • 👤 Paul F. Sieving
  • 👤 Alan D. Watson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 01:24
CPC Classifications
A; A61; A61K; A61K49/00; A61K49/06; A61K49/08; A61K49/10; A61K49/14; A61K49/143; A61K47/00; A61K47/50; A61K47/51; A61K47/54; A61K47/547; A61K47/62; A61K47/64; A61K47/645; A61K49/085; A61K49/101; A61K49/106; A61K49/12; A61K49/126; A61K49/128; A61K49/146; A61K51/00; A61K51/02; A61K51/04; A61K51/06; A61K51/065; C; C08; C08G; C08G69/00; C08G69/48

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 143 words
A mixed carboxycarbonic anhydride adduct of a macrocyclic chelant selected from the group consisting of the residues of 1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA), 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid (DO3A), 1-oxa-4,7,10-triazacyclododecane-triacetic acid (OTTA), 1,4,7-triazacyclononanetriacetic acid (NOTA), 1,4,8,11-tetraazacyclotetradecanetetraacetic acid (TETA), DOTA-N(2-aminoethyl)amide and DOTA-N(2-aminophenethyl)amide formed by a process comprising the following steps: (a) dispersing a carboxylic macrocyclic chelant in a polar, anhydrous solvent; (b) adding a base with a pKa sufficient to remove all carboxyl protons to create an amine salt of said chelant soluble in said solvent; (c) chilling the reaction mixture to between about 5° C. and 55° C. above the freezing point of the solvent; and (d) adding a substantially equimolar amount of chilled alkylhaloformate under anhydrous conditions while approximately maintaining the temperature of step (c) for a period of time sufficient for substantially complete reaction to form a slurry containing the mixed carboxycarbonic anhydride of the chelant.
Claim 2
Dependent Claim 143 words
A mixed carboxycarbonic anhydride adduct of a macrocyclic chelant selected from the group consisting of the residues of 1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA), 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid (DO3A), 1-oxa-4,7,10-triazacyclododecane-triacetic acid (OTTA), 1,4,7-triazacyclononanetriacetic acid (NOTA), 1,4,8,11-tetraazacyclotetradecanetetraacetic acid (TETA), DOTA-N(2-aminoethyl)amide and DOTA-N(2-aminophenethyl)amide formed by a process comprising the following steps: (a) dispersing a carboxylic macrocyclic chelant in a polar, anhydrous solvent; (b) adding a base with a pKa sufficient to remove all carboxyl protons to create an amine salt of said chelant soluble in said solvent; (c) chilling the reaction mixture to between about 5° C. and 55° C. above the freezing point of the solvent; and (d) adding a substantially equimolar amount of chilled alkylhaloformate under anhydrous conditions while approximately maintaining the temperature of step (c) for a period of time sufficient for substantially complete reaction to form a slurry containing the mixed carboxycarbonic anhydride of the chelant.
Claim 3
Dependent Claim 17 words
An adduct according to claim 1 formed using an aprotic solvent as the solvent of step (a).
Claim 4
Dependent Claim 19 words
An adduct according to claim 1 formed using dry acetonitrile, dimethylacetamide or dimethylformamide as the solvent of step (a).
Claim 5
Dependent Claim 18 words
An adduct according to claim 1 formed using tetramethylguanidine, 1,5-diazabicyclo[4.3.0]non-5-ene, or 1,8-diazabicyclo[5.4.0]undec-7-ene as the base of step (b).
Claim 6
Dependent Claim 15 words
An adduct according to claim 1 formed using isobutylchloroformate as the alkylhaloformate of step (d).

References Cited (Backward Citations)

US4647447A Cited
US4741900A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-09-10 2000-03-11 2000-09-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-09-10 2004-03-11 2004-09-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-09-10 2008-03-11 2008-09-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag